Dr. Mozard Mohtar (PhD, Aston University) is an academic and consultant with focused expertise in brand management for services and retailing, psychometrics, and multivariate analyses. Based at Universiti Malaya Graduate School of Business, he combines academic knowledge with practical industry experience to support clients and students in navigating complex market dynamics and building effective brand strategies. As an accredited HRD Corp Trainer, Dr. Mozard has collaborated with clients such as Infineon Technologies (Malaysia) Sdn. Bhd. and Panasonic Industrial Devices Malaysia Sdn. Bhd., providing tailored corporate training and consultation. His approach emphasizes data-driven insights, guiding businesses in refining brand positioning and improving customer engagement strategies. Dr. Mozard’s work is rooted in making complex analytics accessible, turning insights into strategies that drive immediate improvements. Beyond research and consultancy, he is dedicated to mentorship and professional development, regularly participating in both academic and industry conferences, while collaborating with partners on emerging challenges. Dr. Mozard values bridging academic perspectives with industry needs to foster sustainable, meaningful brand growth.

Azizan Baharuddin received her BSc (Hons) in Biology from the University of Tasmania, Australia in 1978, MSc (Univ. College London) in 1979 and PhD in Philosophy of Science (Science & Islam) from University of Lancaster, United Kingdom in 1989. She specialises in several areas such as environmental ethics, religion and sustainable development, Islam and science, bioethics, interfaith/intercivilisational dialogue. She has published more than 300 books, book chapters, monographs, journal articles and newspaper articles in the above-mentioned fields, including books Harmony between Religion and Science: An Islamic Perspective (2019), Environmental Ethics in Islam (2018), co-editor of Islam and Ecology: A Bestowed Trust (2003) and Environment, Values and the Future of Civilisations (2013). She is active in several governmental and non-governmental organisations connected with her areas of specialisation, as well as being a member of various advisory and consultative committees for various ministries in Malaysia. She was appointed by the Prime Minister as the Chairman of the National Committee for the Promotion of Understanding and Harmony Among Religious Adherents (JKMPKA) (2014–2015); appointed by the Minister of Science, Technology and Innovation as Chairman of the National Bioethics Council (MBEN) (2014-2017). She was appointed by the Director-General of UNESCO as Member of the International Bioethics Committee (IBC) in Paris (2014-2017). Due to her works and contributions in the area of Science & Religion, she received an award from the Centre for Theology & Natural Sciences, USA in 2001. She was also awarded the Federal Territory Maal Hijrah Award in 2016. In 2016, she received the Langkawi Award from the Ministry of Natural Resources and Environment (NRE) for her work in environmental education and activism at the national level and abroad. She was a lead member of the drafting team for the Islamic Declaration on Global Climate Change (IDCC) endorsed by the UN United Nations Framework Convention on Climate Change (UNFCCC) and submitted to the President of the 70th United Nations General Assembly (UNGA), New York in 2016. She was appointed by the Yang Di-Pertuan Agong as Member of the Majlis Kebangsaan Bagi Hal Ehwal Ugama Islam Malaysia (MKI) (2018 – 2021). She is also member of the Board of Advisors for the Legasi Tun Abdullah Ahmad Badawi (LEGASI), appointed member of the Board of Directors of Dewan Bahasa & Pustaka (DBP) (2016-2019), Director (Non-Executive) and Shariah Advisory Council of QSR Brands Holdings (M) Berhad (2017-2020), and appointed member of Notes and Coins Advisory Committee (NCAC), Bank Negara Malaysia (2017-2021). Recently, she has been appointed by the YAB Prime Minister as member of the Consultative Panel of the Malaysia Anti-Corruption Commission (MACC) (2020 – 2022). She was appointed as Director-General of IKIM (2015 – 31st August 2021). Currently, she is the Chairholder of UKM-YSD Chair for Sustainability, Director of Centre for Civilisational Dialogue, Universiti Malaya as well as Member of Majlis Kebangsaan Bagi Hal Ehwal Ugama Islam Malaysia (MKI) (2021-2023).

Associate Professor Dr. Chen Yeng is an expert in cancer biomarker discovery, biosensor development, and natural therapeutics, with a multidisciplinary approach that bridges nanotechnology, molecular biology, and biomedicine. Her expertise is particularly evident in her work on innovative diagnostic technologies and personalized therapeutic solutions, targeting both cancer and infectious diseases.  Her research interests span several cutting-edge areas. One of her primary focuses is the identification and characterization of cancer biomarkers, particularly through novel approaches targeting at immunogenic host proteins. This line of research explores how immunogenic proteins’ interventions might modulate cancer risk, representing an innovative intersection of microbiology, proteomics, and oncology.  Dr. Chen is also deeply engaged in developing advanced diagnostic tools, including nanobiosensors with enhanced sensitivity and specificity. These devices, designed to detect critical biomarkers such as those associated with tuberculosis, blood clotting disorders, and oral cancer, are transformative for early disease detection. Her work in biosensors, utilizing materials like gold nanoparticles and zinc oxide nanolayers, has set new standards in diagnostic accuracy and reliability.  Another cornerstone of her research is the study of natural plant extracts for therapeutic applications, particularly in cancer treatment. She investigates the biochemical and pharmacological properties of these extracts, focusing on their mechanisms of action, such as inducing apoptosis, causing cell cycle arrest, and promoting mitochondrial dysfunction in cancer cells. Her exploration of natural products' roles in modulating microRNAs further highlights her innovative approach to cancer research.  Dr. Chen’s expertise also extends to the antioxidant, hepatoprotective, and genoprotective properties of herbal compounds, offering potential preventive and therapeutic solutions for chronic diseases. These studies underline her commitment to sustainable and natural approaches in healthcare.  Her contributions to genomics and proteomics, particularly in large-scale screening for biological markers, further demonstrate her role as a leader in translating complex biological data into meaningful clinical applications. By combining her deep understanding of molecular biology with a focus on real-world impact, Dr. Chen has established herself as a pioneer in her field.  Dr. Chen’s academic influence is demonstrated by her impressive h-index of 28 (ResearchID) and 39 (Scopus), with over 4,500 citations to her name. Her extensive publication record spans high-impact journals, contributing significantly to advancements in dentistry, oncology, and biomedical engineering. She is recognized as a top scientist in Malaysia, ranking among the leading figures in dentistry according to the AD Scientific Index. As a respected peer reviewer for prestigious journals, including Coordination Chemistry Reviews, Periodontal 2000, Biosensors and Bioelectronics, and Cancer Letters, Dr. Chen plays a critical role in maintaining the quality of research within her fields of expertise. Her contributions extend to academic leadership, where she had supervised and graduated over 20 postgraduate students, including 11 PhD candidates, nurturing the next generation of scientific leaders. Her leadership in dental education accreditation has further solidified her impact on academic excellence. She has played pivotal roles in the reaccreditation of dental programs at the University of Malaya and other institutions, ensuring that these programs meet global standards. Through her commitment to interdisciplinary collaboration, Dr. Chen has partnered with industry leaders to translate research findings into practical healthcare solutions, such as rapid diagnostic tools and personalized treatments. These collaborations exemplify her ability to bridge scientific discovery with real-world applications. In summary, Dr. Chen’s expertise and research interests reflect a holistic approach to biomedical science, integrating cutting-edge technologies with sustainable practices. Her work not only pushes the boundaries of knowledge in cancer research and diagnostics but also has the potential to transform patient care and public health globally.